Quality by design (QbD) based development and validation of an HPLC method for amiodarone hydrochloride and its impurities in the drug substance
Authors:
- 17 July 2014
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 100, 167-174
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Improved quality-by-design compliant methodology for method development in reversed-phase liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2013
- Quality by Design: Design of Experiments Approach Prior to the Validation of a Stability-Indicating HPLC Method for MontelukastChromatographia, 2013
- Applying QbD Principles To Develop a Generic UHPLC Method Which Facilitates Continual Improvement and Innovation Throughout the Product Lifecycle for a Commercial APIOrganic Process Research & Development, 2013
- Expanding the term “Design Space” in high performance liquid chromatography (I)Journal of Pharmaceutical and Biomedical Analysis, 2011
- Quality by Design (QbD) Based Development of a Stability Indicating HPLC Method for Drug and ImpuritiesJournal of Chromatographic Science, 2011
- Development of Quality-By-Design Analytical MethodsJournal of Pharmaceutical Sciences, 2011
- Validation of a Stability Indicating LC Method for Amiodarone HCL and Related SubstancesChromatographia, 2005
- Characterization of amiodarone metabolites and impurities using liquid chromatography/atmospheric pressure chemical ionization mass spectrometryRapid Communications in Mass Spectrometry, 2000
- Liquid Chromatographic Determination of Amiodarone Hydrochloride and Related Compounds in Raw Materials and TabletsJournal of AOAC INTERNATIONAL, 1994